Corcept Therapeutics Inc
CORT
ISIN US2183521028 / Valor 1812837
Corcept Therapeutics Inc
UMushroom community rating:
About company
Corcept Therapeutics Inc is a pharmaceutical company that focuses on the discovery, development, and commercialization of drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders. The company's board members, such as Daniel N. Swisher, Jr. and Gillian M. Cannon, bring extensive experience in the pharmaceutical industry, including leadership roles at prominent companies like Jazz Pharmaceuticals, Sunesis Pharmaceuticals, Merck and Co. Inc., UCB Inc., and Otsuka Pharmaceuticals. With a strong emphasis on research and development, Corcept Therapeutics Inc aims to provide innovative solutions to address unmet medical needs in various therapeutic areas.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
5498 M
Market cap (USD)
1,038,417
Daily traded volume (Shares)
51.95 / 50.17
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
